Omicron News and Research

RSS
Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

Additional boosters recommended for certain individuals at higher risk of severe COVID-19 outcomes

31 Mar 2022
KHN’s ‘What the Health?’: Funding for the next pandemic

KHN’s ‘What the Health?’: Funding for the next pandemic

31 Mar 2022
NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

NIH-sponsored trial of second COVID-19 booster shots begins enrolling adult participants

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

31 Mar 2022
Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

31 Mar 2022
‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

‘The danger is still there’ ― As omicron lurks, Native Americans are wary of boosters

31 Mar 2022
Booster doses provide strong protection against hospitalization and death from COVID-19

Booster doses provide strong protection against hospitalization and death from COVID-19

30 Mar 2022
Inconsistency in disease severity across SARS-CoV-2 variants

Inconsistency in disease severity across SARS-CoV-2 variants

30 Mar 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

30 Mar 2022
Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

30 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

Study describes the identification of a SARS-CoV-2 variant that escapes detection by antigen tests

30 Mar 2022
Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

Immunity against SARS-CoV-2 BA.1, BA.2, and BA.3 after three doses of BNT162b2 vaccine

29 Mar 2022
Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

29 Mar 2022
A bioinformatics approach for detecting SARS-CoV-2 co-infections

A bioinformatics approach for detecting SARS-CoV-2 co-infections

29 Mar 2022
FDA approves second COVID-19 booster dose for older and immunocompromised individuals

FDA approves second COVID-19 booster dose for older and immunocompromised individuals

29 Mar 2022
Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

29 Mar 2022
Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

29 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback